Literature DB >> 20172610

Development of a bioassay to monitor circulating plasma Ki-67.

Gary Hardiman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20172610      PMCID： PMC3108860          DOI： 10.1016/j.leukres.2010.01.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  15 in total

Review 1.  The Ki-67 protein: fascinating forms and an unknown function.

Authors:  E Endl; J Gerdes
Journal:  Exp Cell Res       Date:  2000-06-15       Impact factor: 3.905

Review 2.  Ki67 protein: the immaculate deception?

Authors:  D C Brown; K C Gatter
Journal:  Histopathology       Date:  2002-01       Impact factor: 5.087

Review 3.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

4.  Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

Authors:  William J M Hrushesky; Michael Retsky; Michael Baum; Romano Demicheli
Journal:  J Natl Cancer Inst       Date:  2007-06-27       Impact factor: 13.506

5.  Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67.

Authors:  L Qiao; S J Shiff; B Rigas
Journal:  Cancer Lett       Date:  1997-05-19       Impact factor: 8.679

6.  Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.

Authors:  T P Miller; T M Grogan; S Dahlberg; C M Spier; R M Braziel; P M Banks; K Foucar; C R Kjeldsberg; N Levy; B N Nathwani
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

7.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

8.  Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?

Authors:  C Ahlin; K Aaltonen; R-M Amini; H Nevanlinna; M-L Fjällskog; C Blomqvist
Journal:  Histopathology       Date:  2007-08-17       Impact factor: 5.087

9.  Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.

Authors:  Katarzyna Szczuraszek; Grzegorz Mazur; Michał Jeleń; Piotr Dziegiel; Paweł Surowiak; Maciej Zabel
Journal:  Anticancer Res       Date:  2008 Mar-Apr       Impact factor: 2.480

10.  Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer.

Authors:  J Lee; Y H Im; S H Lee; E Y Cho; Y L Choi; Y H Ko; J H Kim; S J Nam; H J Kim; J S Ahn; Y S Park; H Y Lim; B K Han; J H Yang
Journal:  Cancer Chemother Pharmacol       Date:  2007-05-17       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.